Data as of Jan 30
| -0.015 / -3.02%|
The 2 analysts offering 12-month price forecasts for Titan Pharmaceuticals Inc have a median target of 1.78, with a high estimate of 2.30 and a low estimate of 1.25. The median estimate represents a +268.27% increase from the last price of 0.48.
The current consensus among 2 polled investment analysts is to Buy stock in Titan Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.